New MRI contrast agent detects invasive lung cancer earlier
Source ↗
👁 0
💬 0
Researchers have developed a new class of protein-based MRI contrast agent that detects invasive lung cancer and metastatic disease at earlier stages than conventional imaging approaches.
Results of this research in the journal Science Advances report a precision MRI method that can identify tumors and metastases as small as 1 millimeter.
“This is a game changer for cancer diagnosis and precision medicine.”
“Lung cancer is often diagnosed only after it has spread, when treatmen
Results of this research in the journal Science Advances report a precision MRI method that can identify tumors and metastases as small as 1 millimeter.
“This is a game changer for cancer diagnosis and precision medicine.”
“Lung cancer is often diagnosed only after it has spread, when treatmen
Comments (0)